Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Ketamine Found to Alleviate Depression

April 13, 2015 8:21 am | by University of Hertfordshire | News | Comments

Researchers have found that Ketamine, which has a reputation as an illicit recreational drug, has an extremely large depression reducing effect. Read more...


Ebola Still Global Emergency Despite Big Drop in Cases

April 13, 2015 8:21 am | by Maria Cheng, AP Medical Writer | News | Comments

The World Health Organization said the year-long Ebola outbreak in West Africa still qualifies as an international emergency even though the number of cases has plummeted. Read more...


First Look at 'Wasabi Receptor' Brings Insight for Pain Drug Development

April 10, 2015 10:51 am | by Peter Farley, UCSF | News | Comments

Protein’s structure will guide hunt for new treatments of inflammation-induced pain. Read more...


Scientists Find Molecular Trigger of Schizophrenia - Like Behaviors

April 10, 2015 10:21 am | by The Scripps Research Institute | News | Comments

The research gives scientists new tools for someday preventing or treating psychiatric disorders such as schizophrenia, bipolar disorder and autism. Read more...


Suit Claims AIDS Foundation Scammed Medicare for $20M

April 10, 2015 10:11 am | by Kelli Kennedy, Associated Press | News | Comments

One of the nation's largest suppliers of HIV and AIDS medical care is accused of bilking Medicare and Medicaid in an elaborate $20 million dollar scam that spanned 12 states. Read more...


Oncolytics Files for Orphan Drug Designation with FDA for Gastric Cancer

April 9, 2015 5:14 pm | News | Comments

Oncolytics Biotech Inc. announced that it has submitted an application for Orphan Drug Designation to the U.S. Food and Drug Administration ("FDA") for Reolysin for the treatment of gastric cancer.  Read more


Breast Cancer Cells May Spread by Mimicking Blood Vessels

April 9, 2015 5:10 pm | by Cancer Research UK | News | Comments

U.S. scientists have discovered how tumor cells that mimic blood vessels could help breast cancer to spread around the body. Read more...

Genetic Screening Could Improve Breast Cancer Prevention

April 9, 2015 5:03 pm | by University of Cambridge | News | Comments

A test for a wide range of genetic risk factors could improve doctors’ ability to work out which women are at increased risk of developing breast cancer, a major study of more than 65,000 women has shown. Read more...


NIH Funds Nine Antimicrobial Resistance Diagnostics Projects

April 9, 2015 4:57 pm | by NIH | News | Comments

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded more than $11 million in first-year funding for nine research projects supporting enhanced diagnostics to rapidly detect antimicrobial-resistant bacteria. Read more..


Inovio to Lead $45M Program to Expedite Product Development for Ebola

April 9, 2015 4:43 pm | News | Comments

Inovio Pharmaceuticals, Inc. announced that the company has been selected to receive a grant from the Defense Advanced Research Projects Agency (DARPA) to lead a collaborative team to develop multiple treatment and prevention approaches against Ebola. Read more..


EU Approves Roche’s Avastin Therapy

April 9, 2015 4:25 pm | News | Comments

Roche announced that the European Commission (EU) approved Avastin (bevacizumab) in combination with standard chemotherapy (paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in patients who cannot receive platinum therapy) for the treatment of adult patients with persistent, recurrent or metastatic carcinoma of the cervix. Read more...


30% of Consumers Take Action After Viewing Prescription Ads: Study

April 9, 2015 12:52 pm | News | Comments

According to a new survey by, nearly 30 percent of consumers have been prompted into action by direct to consumer (DTC) advertising for an Rx (prescription) medication. Read more...


Prolong Pharmaceuticals' SCD Treatment Gets Orphan Drug Designation

April 9, 2015 12:43 pm | News | Comments

Prolong Pharmaceuticals, LLC, a biopharmaceutical company dedicated to developing products for the treatment of anemias, cancers and their debilitating comorbidities, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its flagship product Sanguinate for the treatment of Sickle Cell Disease (SCD). Read more...


Cellular Defect Linked to Diabetes

April 9, 2015 12:33 pm | by Columbia University | News | Comments

A cellular defect that can impair the body’s ability to handle high glucose levels and could point the way to a potential new treatment for diabetes has been identified by Columbia University Medical Center (CUMC) researchers. Read more..


Researchers Deliver Large Particles into Cells at High Speed

April 9, 2015 12:27 pm | by UCLA | News | Comments

A new device developed by UCLA engineers and doctors may eventually help scientists study the development of disease, enable them to capture improved images of the inside of cells and lead to other improvements in medical and biological research. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.